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Mucopolysaccharidoses 
The mucopolysaccharidoses (MPS) are lysosomal storage disorders caused 
by the deficiency of enzymes required for the stepwise breakdown of 
glycosaminoglycans (GAGs), previously known as mucopolysaccharides 
(1-5). Fragments of partially degraded GAGs accumulate in the lysosomes, 
resulting in cellular dysfunction and clinical abnormalities. These are 
rare conditions, with an estimated total incidence of all types of MPS of 
approximately 1 in 20,000 live births. Mucopolysaccharidoses  are hereditary, 
progressive disease caused by mutations of genes coding  for lysosomal 
enzymes needed to degrade glycosaminooglycans. Mucopolysaccharidoses 
are autosomal recessive disorders, with the exception of hunter disease which 
is x-linked recessive. Their overall frequency is between 3.5/100000 and 
4.5/100000. The most common subtype is MPS–III (Sanfilippo), followed 
by MPS-I (Hurler) and MPS-II (Hunter).
Hurler disease: Presenting symptoms included joint stiffness, corneal 
clouding, and recurrent ear, nose, and throat complaints. The patient appears 
normal at birth, but inguinal hernias are often present.  Inguinal and umbilical 
hernias resulting from connective tissue abnormalities are common, 
especially in MPS I, II, VI, and VII (2,6-7). They may occur early, as part 
of the initial presentation, and can become quite large (8). Hernias can also 
occur at the incision site following abdominal surgery. Hepatosplenomegaly 
between 6-24 month may contribute to increased intra-abdominal pressure 
and lead to hernia formation.
Surgical repair of inguinal hernias often fails and needs to be repeated. 
Hepatosplenomegaly and the weak connective tissues may contribute 
to poor results. Thus, in some patients, management with trusses may be 
preferable to the risk of anesthesia and a surgical repair that is likely to be 
temporary. Large umbilical hernias that occur in MPS I should be repaired 
when possible, as their size can lead to breakdown of the overlying skin. 
Diarrhea — MPS II and III patients may develop recurrent or chronic 
diarrhea. The mechanism is thought to be MPS storage in the neurons of 
the myenteric plexus, leading to abnormal motility (9). Although motility 
has not been directly studied, storage in these cells has been demonstrated 
in biopsies of the intestinal wall (10). Diarrhea can be improved with 
medications that decrease bowel motility(10).
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Hunter disease: gastrointestinal storage may produce 
chronic diarrhea.
Sanfilippo disease and MPS-IV: Physical findings 
are milder than in Hurler syndrome and include 
typical coarse facial features, dysostosis multiplex, 
hepatosplenomegaly, and hernias.
Gaucher disease
Gaucher disease (GD) is an inborn error of metabolism 
that affects the recycling of cellular glycolipids. 
Glucocerebroside (also called glucosylceramide) 
and several related compounds that are ordinarily 
degraded to glucose and lipid components accumulate 
within the lysosomes of cells.
GD is one of the few inherited metabolic disorders 
that can be treated by replacement of the deficient 
enzyme (enzyme replacement therapy). Because early 
treatment can prevent development of irreversible 
complications, early identification is crucial to 
improving ultimate outcome (1).
This disease is a multisystemic lipidosis characterized 
by hematologic problems, organomegaly, and 
skeletal involvement. Gaucher  disease results from 
the deficient activity of the lysosomal hydrolase, acid 
ß-glucosidase.
Gastrointestinal manifestation including: progressive 
massive hepatomegaly (all types; moderate to severe 
63% at presentation)  with or without  elevated liver 
function results, cholestasis, Splenomegaly (all types; 
moderate to severe 85% at presentation), ascites, FTT.
Liver cirrhosis, portal hypertension, esophageal 
varices, upper gastrointestinal bleeding and acute 
liver failure has been reported. Hepatosplenomegaly 
may be asymptomatic or may be associated with early 
satiety, abdominal complaints (distension, discomfort, 
pain), and/or anemia and thrombocytopenia.
Neimann pick disease
Hepatic and gastrointestinal manifestation of 
NPD characterized by prolonge neonatal jaundice, 
cholestasis, hepatomegaly, splenomegaly, liver 
cirrhosis, ascites, portal hypertension, esophageal 
varices and upper gastrointestinal bleeding, 
progressive dysphagia makes oral feeding impossible.
